Actively Recruiting
A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain
Led by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2025-04-20
80
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective, randomized, parallel-controlled clinical trial to evaluate the effectiveness and safety of chronic pain rehabilitation training software in assisting in the relief of chronic secondary musculoskeletal pain
CONDITIONS
Official Title
A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females 6518 years old
- Average pain intensity 64 on a 0-10 numerical rating scale in the past 24 hours
- Able to communicate in Chinese
- Able to read and write Chinese
- Willing to comply with study procedures and restrictions
- Willing and able to sign informed consent
You will not qualify if you...
- Shingles on eyes, ears, head, face, or hands
- Trigeminal neuralgia
- Severe vision impairment (corrected vision with glasses or contacts allowed)
- Severe hearing impairment
- Medical conditions causing nausea or dizziness (e.g., insufficient brain blood supply, vestibular dysfunction, cholecystitis)
- History of severe motion sickness
- Injuries to eyes, ears, face, or neck preventing comfortable use of mixed reality
- Injury or dysfunction of hands or upper limbs preventing comfortable use of mixed reality
- Diagnosis of cognitive impairment, epilepsy, dementia, migraines, or other neurological diseases preventing mixed reality use
- History of mental illness including depression, generalized anxiety disorder, schizophrenia
- Females currently pregnant
- Participation in another interventional clinical study within 4 weeks before screening
- Investigator's judgment of unsuitability for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xinhua hospital ,Shanghai Jiaotong University, School of medicine
Shanghai, Shanghai Municipality, China, 20000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here